Mediracer is preparing to enter the US market after the US Food and Drug Administration (FDA) 510(k) review for premarket notification for the Mediracer® NCS device was successfully completed (SE) and clearance to market the device in the US was granted. The...

Mediracer is preparing to enter the US market after the FDA 510(k) review for premarket notification for the Mediracer® NCS system was successfully completed (SE) for our CTS Carpal Tunnel Syndrome and DPN Diabetic Peripheral Neuropathy measurement. Section 510(k) of...

We are proud to assist The Best Practice annual conference with our distributor Henry ScheinWhat is Best Practice and Best Practice in Nursing Best Practice is the UK’s national event for general practice. It uniquely brings together over 5,700 decision makers and key...

Come and meet us! We are attending at the stand number (#24) Mediracer Ltd was founded in 2002 to develop Point of Care products in the field of clinical neurophysiology for patient examinations adapted to the needs of primary health care and hand clinics. The target...

Our stand in the BSSH and BAHT Spring 2019 Scientific Meeting   24-26 April 2019 Great Hall, Swansea University Bay Campus The aims of the BSSH are to promote and direct the development of Hand Surgery, to foster and co-ordinate education, study and research in...

Mediracer on mukana Medica 2018 -messuilla marraskuun 12-15, Düsseldorfissa Saksassa. Olemme Business Finlandin ja Business Oulun organisoimalla yhteisständillä, Hall 15 booth E55 – Tervetuloa meitä tapaamaan!

Mediracer on mukana Medica 2018 -messuilla Düsseldorfissa Saksassa, marraskuun 12-15. Tervetuloa tapaamaan meitä Business Finlandin ja Business Oulun organisoimalle Finland Pavilion -yhteyisständille, Hall 15 / E55! https://www.medica-tradefair.com/